Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| FEDERAL MOGU | FDML | 6.13% |
| RADIANT LOGI | RLGT | 5.32% |
| NATUS MEDICA | BABY | 5.27% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Coffee giant Starbucks Corporation ( SBUX - Analyst Report ) is looking to expand its coffee offerings, re-introduce an old coffee favorite besides launching new Petites pies and tarts.
Expanded Coffee Offerings
Starbucks is offering its customers a wide selection of hot and iced espresso beverages which they can tailor make to suit their taste. The customers can choose from a variety of dairy selections, syrups, toppings, or can simply add extra shots to customize their coffees. Moreover, Starbucks is also offering a 50% discount to customers who buy any coffee before 11 a.m. and return to buy a second coffee after 2 p.m. the same day. However, the discount can only be availed on the coffee bought after 2 p.m. The offer will be valid from March 8 to March 14.
New Pies and Tarts
Starbucks has also expanded the range of its delicacies that go perfectly well with its coffees and also suffice as a short afternoon snack. The company has introduced new pies (apple pie, cherry pie) and tarts (brown sugar walnut and chocolate hazelnut tarts) under the Petites brand. These are available for $1.50 each, two for $2.50, and six for $7.50 plus tax if applicable.
Return of Tribute Blend
On popular demand, Starbucks has re-launched an old favorite coffee, Tribute Blend, which combines four of Starbucks all-time favorite coffees: Aged Sumatra, Sun-dried Ethiopia, Papua New Guinea, and Colombia coffees.
Our Take
We currently have a Neutral recommendation on Starbucks. However, the stock carries a Zacks #2 Rank (a short-term ‘Buy’ rating).
Continuous product innovation has always helped the company maintain decent earnings growth. The expanded product offerings discussed above will widen Starbucks’ portfolio and push its top line forward.
However, intense competition from peers like Dunkin Brands ( DNKN - Snapshot Report ) , McDonald's ( MCD - Analyst Report ) , and Green Mountain Coffee Roasters, Inc ( GMCR - Analyst Report ) coupled with high coffee prices on account of bad weather conditions and an abnormal increase in farming costs induces us to maintain a sideline view on the stock.
Read the full reports :
Analyst Report on SBUX
Analyst Report on MCD
Analyst Report on GMCR
Snapshot Report on DNKN